US Stock MarketDetailed Quotes

ALT Altimmune

Watchlist
  • 6.230
  • +0.080+1.30%
Close Oct 4 16:00 ET
  • 6.195
  • -0.036-0.57%
Post 19:58 ET
442.77MMarket Cap-3822P/E (TTM)

Altimmune Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Altimmune Q2 2024 Earnings Date

Currency：USDAug 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
620.00
5.00K
+4.38K
Beat Est.
-89.67%
-16.67%
+706.45%
EPS
-0.34
-0.35
-<0.01
Miss Est.
-7.81%
-9.37%
-1.48%
Analyst Rating
Strong Buy

Sep 30, 2024

Altimmune Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 31.251M--
--2024/Q3-- / 620.000--
Aug 8, 20242024/Q25.000K / 620.000--
May 9, 20242024/Q15.000K / 0.000--
Mar 27, 20242023/Q437.000K / 2.140K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 31.251M--
--2024/Q3-- / 620.000--
Aug 8, 20242024/Q25.000K / 620.000--
May 9, 20242024/Q15.000K / 0.000--
Mar 27, 20242023/Q437.000K / 2.140K--

Unlock Free Earnings Estimates

Altimmune Earnings Reports

  • Altimmune | 10-Q: Q2 2024 Earnings Report

    Aug 8 16:10 ET

  • Altimmune | 10-Q: Q1 2024 Earnings Report

    May 9 17:13 ET

  • Altimmune | 10-K: FY2023 Annual Report

    Mar 27 16:05 ET

  • Altimmune | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 16:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Weight Loss Drugs
    Weight Loss Drugs
    Intraday+0.26%